Navigation Links
MAP Pharmaceuticals to Present Data Showing Low Migraine Recurrence Rates With LEVADEX™ in FREEDOM-301 Trial
Date:10/29/2010

potential treatment of migraine and has reported positive results from the efficacy portion of its Phase 3 trial of LEVADEX. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.

Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com.

Forward-Looking Statements In addition to statements of historical facts or statements of current conditions, this press release contains forward-looking statements, including with respect to MAP Pharmaceuticals' LEVADEX product candidate. Actual results may differ materially from current expectations based on risks and uncertainties affecting the Company's business, including, without limitation, risks and uncertainties relating to the conduct and completion of clinical trials, and relating to the preparation and filing of a New Drug Application and the regulatory process to have the Company's LEVADEX product candidate approved for commercial use. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law. Additional information on potential factors that could affect MAP Pharmaceuticals' results and other risks and uncertainties are detailed in its Quarterly Report on Form 10-Q for the quarter ended June 30, 2010, available at http://edgar.sec.gov. CONTACTS:Nicole FoderaroWCG(415) 946-1058nfoderaro@wcgworld.com
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... Redwood Pharma AB has entered into a ... both the US and China , ... hydrogel technology in its lead chronic Dry Eye therapeutic ... technology offers many unique competitive benefits. At lower temperatures, ... low concentrations of polymer the system can be transitioned ...
(Date:7/2/2015)... BGI a annoncé aujourd,hui que son ... situé à Hong Kong ... Pathologists  (Collège des pathologistes américains, ou CAP). Les ... constituent le premier laboratoire clinique de ... du CAP en Chine, car il satisfait les ...
(Date:7/2/2015)... and VANCOUVER , July 2, 2015 ... EPI) announced today that its common shares have been approved ... under the symbol "EPIX". ESSA will begin trading ... its listing on the TSX Venture Exchange under the symbol ... the common shares on the NASDAQ, each of the Company,s ...
Breaking Medicine Technology:Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2BGI obtient la certification du Collège des pathologistes américains (CAP) 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4
(Date:7/6/2015)... ... July 06, 2015 , ... Cancer ... cancer patients, caregivers and medical professionals to chat with the CHN patient services ... , “Receiving a cancer diagnosis is often the most traumatic experience of a ...
(Date:7/6/2015)... ... July 06, 2015 , ... With a new community ... teamed up with Family Emergency Shelter Coalition (FESCO) and announced a new charity ... created especially to provide emergency services and support for homeless families, all the ...
(Date:7/6/2015)... ... , ... With a new community program in the Livonia, Canton and Plymouth ... a new charity campaign to raise funds in support of the health and safety ... Our Youth is a coalition created especially to educate and empower teens, bringing awareness ...
(Date:7/6/2015)... Rockville, MD (PRWEB) , ... July 06, 2015 , ... ... MD, and Washington, DC, area patients. Kybella is a non-surgical method to ... the use of reducing moderate to severe fat deposits under the chin, commonly known ...
(Date:7/6/2015)... ... July 06, 2015 , ... Diabetes affects many of us and the ... Americans have diabetes, the majority of which are Type 2. However, eight million do ... one in three, have prediabetes (abnormally high blood sugar levels). Without reductions in blood ...
Breaking Medicine News(10 mins):Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 2Health News:Bowker Insurance Group and Nonprofit Livonia Save Our Youth Initiate New Charity Campaign in Livonia, MI to Provide for The Health and Safety of The Communities’ Youth 3Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2
... of shrinking tumours in certain cancers a finding that ... are those caused by a new class of genes known ... recently, were dismissed as ,junk DNA,. While much is still ... with how our genes are ,read,. The current finding ...
... from routine diagnostic CT, radiologists may be better able to ... a new study appearing online and in the November issue ... show that radiologists can predict cardiovascular disease fairly well using ... along with minimal patient information, such as age, gender and ...
... internationally-recognized expert in spiritually and medicine, will be the ... Social Work,s (GCSW) 13th Annual R.J. DeBottis Memorial Lecture on ... "We are honored to host Dr. Koenig who ... health in people of all ages," said Ira Colby, dean ...
... HealthDay Reporter , MONDAY, Sept. 27 (HealthDay News) -- ... men when their wives or girlfriends are sick: the male ... more likely than other men to be hospitalized for severe ... the men was very small, and the new study doesn,t ...
... The National Cancer Institute has awarded a five-year, $13.6 ... Chapel Hill,s Carolina Center of Cancer Nanotechnology Excellence (C-CCNE) ... research to improve the diagnosis and treatment of cancer ... the continued work of the center launched in 2005 ...
... Reporter , MONDAY, Sept. 27 (HealthDay News) -- There ... other noncarbonated beverages are associated with physical activity they ... In a study of more than 15,000 middle and ... who drank sugar-sweetened beverages, including sports drinks, were more ...
Cached Medicine News:Health News:A revolutionary new way of reversing certain cancers 2Health News:Researchers use CT to predict heart disease 2Health News:Dr. Harold G. Koenig to speak at R.J. DeBottis Lecture on Aging, Nov. 8 2Health News:Male Partners of Breast Cancer Patients May Suffer Depression 2Health News:NCI awards $13.6 million to UNC's Carolina Center of Cancer Nanotechnology Excellence 2Health News:NCI awards $13.6 million to UNC's Carolina Center of Cancer Nanotechnology Excellence 3Health News:Study Finds Teens Think Sports Drinks Are Healthy 2Health News:Study Finds Teens Think Sports Drinks Are Healthy 3
... 25ml pipette in under 3 ... Rechargeable during use. 3 aspirate ... variable speed including gravity dispense ... holder. Low battery light. Suitable ...
Application: Safe and convenient filling and dispensing of glass and plastic pipets....
Inquire...
An adhesive-backed hanger, designed for use where space is limited (fume hoods, sterile hoods, etc.). Sticks to any smooth, dry surface without damage. Resistant to chemicals and UV light....
Medicine Products: